← Evidence map

ArticleOncotarget2017

The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.

Shintaro Fujihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

29 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 28052030